CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015

QT Ostrom, H Gittleman, G Truitt, A Boscia… - Neuro …, 2018 - academic.oup.com
Background CBTRUS is a unique professional research organization that focuses
exclusively on providing high-quality statistical data on the population-based incidence of …

Current FDA-approved therapies for high-grade malignant gliomas

JP Fisher, DC Adamson - Biomedicines, 2021 - mdpi.com
The standard of care (SOC) for high-grade gliomas (HGG) is maximally safe surgical
resection, followed by concurrent radiation therapy (RT) and temozolomide (TMZ) for 6 …

CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019

QT Ostrom, M Price, C Neff, G Cioffi, KA Waite… - Neuro …, 2022 - academic.oup.com
Abstract The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration
with the Centers for Disease Control and Prevention and the National Cancer Institute, is the …

CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017

QT Ostrom, N Patil, G Cioffi, K Waite, C Kruchko… - Neuro …, 2020 - academic.oup.com
Abstract The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration
with the Centers for Disease Control (CDC) and National Cancer Institute (NCI), is the …

CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018

QT Ostrom, G Cioffi, K Waite, C Kruchko… - Neuro …, 2021 - academic.oup.com
Abstract The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration
with the Centers for Disease Control and Prevention (CDC) and National Cancer Institute …

CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016

QT Ostrom, G Cioffi, H Gittleman, N Patil… - Neuro …, 2019 - academic.oup.com
Abstract The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration
with the Centers for Disease Control and Prevention and National Cancer Institute, is the …

Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma

G Agliardi, AR Liuzzi, A Hotblack, D De Feo… - Nature …, 2021 - nature.com
Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain
cancer, for which effective therapies are urgently needed. Chimeric antigen receptor (CAR) …

Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches

K Mitusova, OO Peltek, TE Karpov… - Journal of …, 2022 - Springer
Besides the broad development of nanotechnological approaches for cancer diagnosis and
therapy, currently, there is no significant progress in the treatment of different types of brain …

CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

QT Ostrom, H Gittleman, P Liao… - Neuro …, 2017 - academic.oup.com
Background CBTRUS is a unique professional research organization that focuses
exclusively on providing high quality statistical data on the population-based incidence of …

Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors

P Chongsathidkiet, C Jackson, S Koyama, F Loebel… - Nature medicine, 2018 - nature.com
T cell dysfunction contributes to tumor immune escape in patients with cancer and is
particularly severe amidst glioblastoma (GBM). Among other defects, T cell lymphopenia is …